HUS1900021I1 - Nem nukleozid reverz transzkriptáz inhibitorok - Google Patents

Nem nukleozid reverz transzkriptáz inhibitorok

Info

Publication number: HUS1900021I1
Authority: HU; Hungary
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; nucleoside; inhibitors
Prior art date: 2010-03-30

Application number

HUS1900021C

Other languages

English (en)

Original Assignee

Merck Canada Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-30

Filing date

2019-04-09

Publication date

2019-05-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44710363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1900021(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-04-09 Application filed by Merck Canada Inc filed Critical Merck Canada Inc

2019-05-28 Publication of HUS1900021I1 publication Critical patent/HUS1900021I1/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HUS1900021C 2010-03-30 2019-04-09 Nem nukleozid reverz transzkriptáz inhibitorok HUS1900021I1 (hu)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US31882410P	2010-03-30	2010-03-30
US32157310P	2010-04-07	2010-04-07
EP11761856.1A EP2552902B1 (en)	2010-03-30	2011-03-28	Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number	Publication Date
HUS1900021I1 true HUS1900021I1 (hu)	2019-05-28

Family

ID=44710363

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
HUE11761856A HUE025336T2 (hu)	2010-03-30	2011-03-28	Nem nukleozid reverz transzkriptáz inhibitorok
HUE15157348A HUE031785T2 (hu)	2010-03-30	2011-03-28	Gyógyszerészeti kompozíció, amely tartalmaz nem nukleozid reverz transzkriptáz inhibitort
HUS1900022C HUS1900022I1 (hu)	2010-03-30	2019-04-09	Gyógyszerészeti kompozíció, amely tartalmaz nem nukleozid reverz transzkriptáz inhibitort
HUS1900021C HUS1900021I1 (hu)	2010-03-30	2019-04-09	Nem nukleozid reverz transzkriptáz inhibitorok

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
HUE11761856A HUE025336T2 (hu)	2010-03-30	2011-03-28	Nem nukleozid reverz transzkriptáz inhibitorok
HUE15157348A HUE031785T2 (hu)	2010-03-30	2011-03-28	Gyógyszerészeti kompozíció, amely tartalmaz nem nukleozid reverz transzkriptáz inhibitort
HUS1900022C HUS1900022I1 (hu)	2010-03-30	2019-04-09	Gyógyszerészeti kompozíció, amely tartalmaz nem nukleozid reverz transzkriptáz inhibitort

Country Status (44)

Country	Link
US (2)	US8486975B2 (hu)
EP (2)	EP2552902B1 (hu)
JP (2)	JP5281718B2 (hu)
KR (1)	KR101421861B1 (hu)
CN (1)	CN102971308B (hu)
AR (1)	AR080859A1 (hu)
AU (1)	AU2011235568B2 (hu)
BR (1)	BR112012024691B1 (hu)
CA (1)	CA2794377C (hu)
CL (1)	CL2012002744A1 (hu)
CO (1)	CO6630126A2 (hu)
CR (1)	CR20120503A (hu)
CY (3)	CY1118774T1 (hu)
DK (2)	DK2552902T3 (hu)
DO (1)	DOP2012000256A (hu)
EA (1)	EA024804B1 (hu)
EC (1)	ECSP12012201A (hu)
ES (2)	ES2536295T3 (hu)
FI (1)	FIC20190021I1 (hu)
GE (1)	GEP20156368B (hu)
HN (1)	HN2012002039A (hu)
HR (2)	HRP20150427T1 (hu)
HU (4)	HUE025336T2 (hu)
IL (2)	IL222030A (hu)
LT (3)	LT2924034T (hu)
LU (2)	LUC00113I9 (hu)
MA (1)	MA34170B1 (hu)
ME (2)	ME02181B (hu)
MX (1)	MX2012011379A (hu)
MY (1)	MY163979A (hu)
NI (1)	NI201200146A (hu)
NL (1)	NL300980I2 (hu)
NO (2)	NO2019018I1 (hu)
NZ (1)	NZ602670A (hu)
PE (1)	PE20130158A1 (hu)
PH (1)	PH12012501923A1 (hu)
PL (2)	PL2924034T3 (hu)
PT (2)	PT2924034T (hu)
RS (2)	RS54017B1 (hu)
SG (1)	SG184347A1 (hu)
SI (2)	SI2924034T1 (hu)
TN (1)	TN2012000455A1 (hu)
TW (1)	TWI458719B (hu)
WO (1)	WO2011120133A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME02181B (me) *	2010-03-30	2015-10-20	Merck Canada Inc	Ne-nukleozidni inhibitori reverzne transkriptaze
EP2625292B1 (en)	2010-10-07	2018-12-05	The General Hospital Corporation	Biomarkers of cancer
EP2900240B1 (en) *	2012-09-26	2020-01-08	Merck Sharp & Dohme Corp.	Crystalline form of a reverse transcriptase inhibitor
JO3470B1 (ar) *	2012-10-08	2020-07-05	Merck Sharp & Dohme	مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
CA2892919A1 (en) *	2012-12-05	2014-06-12	Merck Sharp & Dohme Corp.	Process for making reverse transcriptase inhibitors
RU2661399C1 (ru) *	2013-11-22	2018-07-16	Мерк Шарп И Доум Корп.	Композиция ненуклеозидного ингибитора обратной транскриптазы
MX367369B (es)	2013-12-04	2019-08-16	Merck Sharp & Dohme	Proceso para preparar inhibidores de la transcriptasa inversa.
LT3125894T (lt) *	2014-04-01	2020-12-10	Merck Sharp & Dohme Corp.	Živ atvirkštinės transkriptazės inhibitorių provaistai
WO2015200697A1 (en)	2014-06-25	2015-12-30	The General Hospital Corporation	Targeting human satellite ii (hsatii)
US10603282B2 (en)	2015-12-02	2020-03-31	Merck Sharp & Dohme Corp.	Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine
WO2018175271A1 (en) *	2017-03-24	2018-09-27	Merck Sharp & Dohme Corp.	Formulation for parenteral administration
WO2018193470A1 (en)	2017-04-18	2018-10-25	Cipla Limited	Combination therapy for use in treating retroviral infections
CA3090652A1 (en)	2018-02-06	2019-08-15	The General Hospital Corporation	Repeat rna as biomarkers of tumor immune response
WO2020018352A1 (en)	2018-07-17	2020-01-23	Merck Sharp & Dohme Corp.	Hiv drug combination for increasing barrier against resistance
MA54549A (fr)	2018-12-18	2022-03-30	Merck Sharp & Dohme	Dérivés de pyrimidone en tant qu'agents cytotoxiques sélectifs contre des cellules infectées par le vih
CN110801455B (zh) *	2019-11-12	2020-06-02	河北医科大学第二医院	用于治疗mrsa的药物组合物及其应用
CN114163309B (zh) *	2021-12-27	2023-04-25	甘肃皓天医药科技有限责任公司	一种多拉韦林中间体的制备方法
CN114349690B (zh) *	2022-02-15	2023-04-25	甘肃皓天医药科技有限责任公司	一种多拉韦林中间体合成方法
CN116903590A (zh) *	2023-06-06	2023-10-20	延边大学	一种含杂环结构的吡啶酮类化合物及其制备方法和用途
CN120157613A (zh) *	2023-12-15	2025-06-17	山东诚创蓝海医药科技有限公司	多拉韦林中间体及其应用和合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904045D0 (sv)	1999-11-09	1999-11-09	Astra Ab	Compounds
TW200423930A (en) *	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
TW200505441A (en) *	2003-03-24	2005-02-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitorsⅠ
KR20050119652A (ko)	2003-03-24	2005-12-21	에프. 호프만-라 로슈 아게	역전사 효소 저해제로서의 벤질-피리다진온
AU2005235692B2 (en)	2004-04-23	2011-11-10	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
US7166738B2 (en)	2004-04-23	2007-01-23	Roche Palo Alto Llc	Non-nucleoside reverse transcriptase inhibitors
CA2592092A1 (en)	2004-12-22	2006-06-29	Pfizer Limited	Nonnucleoside inhibitors of hiv-1 reverse transcriptase
AR057455A1 (es)	2005-07-22	2007-12-05	Merck & Co Inc	Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
CA2625047A1 (en)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
ATE425138T1 (de)	2005-10-19	2009-03-15	Hoffmann La Roche	N-phenyl-phenylacetamid-nichtnukleosidinhibitor n reverser transkriptase
TW200831085A (en)	2006-12-13	2008-08-01	Merck & Co Inc	Non-nucleoside reverse transcriptase inhibitors
MX2010005483A (es) *	2007-11-20	2010-06-11	Merck Sharp & Dohme	Inhibidores de transcriptasa inversa no nucleosidos.
ME02181B (me) *	2010-03-30	2015-10-20	Merck Canada Inc	Ne-nukleozidni inhibitori reverzne transkriptaze

2011
- 2011-03-28 ME MEP-2015-76A patent/ME02181B/me unknown
- 2011-03-28 CA CA2794377A patent/CA2794377C/en active Active
- 2011-03-28 BR BR112012024691-7A patent/BR112012024691B1/pt active IP Right Grant
- 2011-03-28 NZ NZ602670A patent/NZ602670A/en unknown
- 2011-03-28 HU HUE11761856A patent/HUE025336T2/hu unknown
- 2011-03-28 JP JP2012538161A patent/JP5281718B2/ja active Active
- 2011-03-28 SG SG2012072401A patent/SG184347A1/en unknown
- 2011-03-28 CN CN201180018074.2A patent/CN102971308B/zh active Active
- 2011-03-28 PT PT151573482T patent/PT2924034T/pt unknown
- 2011-03-28 AU AU2011235568A patent/AU2011235568B2/en active Active
- 2011-03-28 LT LTEP15157348.2T patent/LT2924034T/lt unknown
- 2011-03-28 DK DK11761856.1T patent/DK2552902T3/en active
- 2011-03-28 MY MYPI2012004342A patent/MY163979A/en unknown
- 2011-03-28 SI SI201131054A patent/SI2924034T1/sl unknown
- 2011-03-28 ES ES11761856.1T patent/ES2536295T3/es active Active
- 2011-03-28 PT PT117618561T patent/PT2552902E/pt unknown
- 2011-03-28 EA EA201290976A patent/EA024804B1/ru active Protection Beyond IP Right Term
- 2011-03-28 HR HRP20150427TT patent/HRP20150427T1/hr unknown
- 2011-03-28 SI SI201130491T patent/SI2552902T1/sl unknown
- 2011-03-28 PL PL15157348T patent/PL2924034T3/pl unknown
- 2011-03-28 EP EP11761856.1A patent/EP2552902B1/en active Active
- 2011-03-28 PE PE2012001823A patent/PE20130158A1/es active IP Right Grant
- 2011-03-28 MA MA35324A patent/MA34170B1/fr unknown
- 2011-03-28 RS RS20150340A patent/RS54017B1/sr unknown
- 2011-03-28 ME MEP-2016-282A patent/ME02570B/me unknown
- 2011-03-28 RS RS20161093A patent/RS55505B1/sr unknown
- 2011-03-28 GE GEAP201112882A patent/GEP20156368B/en unknown
- 2011-03-28 US US13/073,631 patent/US8486975B2/en active Active
- 2011-03-28 KR KR1020127025733A patent/KR101421861B1/ko active Active
- 2011-03-28 PL PL11761856T patent/PL2552902T3/pl unknown
- 2011-03-28 EP EP15157348.2A patent/EP2924034B1/en active Active
- 2011-03-28 ES ES15157348.2T patent/ES2609636T3/es active Active
- 2011-03-28 HU HUE15157348A patent/HUE031785T2/hu unknown
- 2011-03-28 PH PH1/2012/501923A patent/PH12012501923A1/en unknown
- 2011-03-28 MX MX2012011379A patent/MX2012011379A/es active IP Right Grant
- 2011-03-28 DK DK15157348.2T patent/DK2924034T3/en active
- 2011-03-28 WO PCT/CA2011/000320 patent/WO2011120133A1/en not_active Ceased
- 2011-03-29 TW TW100110833A patent/TWI458719B/zh active
- 2011-03-29 AR ARP110101028A patent/AR080859A1/es active IP Right Grant
2012
- 2012-09-20 IL IL222030A patent/IL222030A/en active Protection Beyond IP Right Term
- 2012-09-20 TN TNP2012000455A patent/TN2012000455A1/en unknown
- 2012-09-27 HN HN2012002039A patent/HN2012002039A/es unknown
- 2012-09-28 NI NI201200146A patent/NI201200146A/es unknown
- 2012-09-28 DO DO2012000256A patent/DOP2012000256A/es unknown
- 2012-09-28 CL CL2012002744A patent/CL2012002744A1/es unknown
- 2012-10-01 CR CR20120503A patent/CR20120503A/es unknown
- 2012-10-01 EC ECSP12012201 patent/ECSP12012201A/es unknown
- 2012-10-01 CO CO12171897A patent/CO6630126A2/es active IP Right Grant
2013
- 2013-05-23 JP JP2013108533A patent/JP5886790B2/ja not_active Expired - Fee Related
- 2013-07-03 US US13/934,633 patent/US20130296382A1/en not_active Abandoned
2014
- 2014-06-23 IL IL233334A patent/IL233334A/en active IP Right Grant
2016
- 2016-12-09 HR HRP20161680TT patent/HRP20161680T1/hr unknown
2017
- 2017-01-25 CY CY20171100114T patent/CY1118774T1/el unknown
2019
- 2019-04-09 HU HUS1900022C patent/HUS1900022I1/hu unknown
- 2019-04-09 HU HUS1900021C patent/HUS1900021I1/hu unknown
- 2019-04-11 LT LTPA2019507C patent/LTC2924034I2/lt unknown
- 2019-04-11 LT LTPA2019506 patent/LTC2552902I2/lt unknown
- 2019-04-16 NL NL300980C patent/NL300980I2/nl unknown
- 2019-04-17 LU LU00113C patent/LUC00113I9/fr unknown
- 2019-04-17 LU LU00114C patent/LUC00114I2/fr unknown
- 2019-04-17 FI FIC20190021C patent/FIC20190021I1/fi unknown
- 2019-04-24 NO NO2019018C patent/NO2019018I1/no unknown
- 2019-04-24 NO NO2019019C patent/NO2019019I1/no unknown
- 2019-05-16 CY CY2019025C patent/CY2019025I1/el unknown
- 2019-05-16 CY CY2019026C patent/CY2019026I2/el unknown

Also Published As

Publication number	Publication date
NO2019018I1 (no)	2019-04-24
IL233334A (en)	2015-09-24
HN2012002039A (es)	2015-08-24
CR20120503A (es)	2013-01-09
DOP2012000256A (es)	2012-12-15
EP2924034A1 (en)	2015-09-30
NI201200146A (es)	2013-03-18
NZ602670A (en)	2014-09-26
EP2552902A4 (en)	2013-09-04
HUE031785T2 (hu)	2017-08-28
CY2019026I1 (el)	2020-05-29
US20110245296A1 (en)	2011-10-06
FIC20190021I1 (fi)	2019-04-17
EP2924034B1 (en)	2016-11-02
AU2011235568A1 (en)	2012-11-01
PE20130158A1 (es)	2013-02-28
RS55505B1 (sr)	2017-05-31
EA024804B1 (ru)	2016-10-31
CA2794377A1 (en)	2011-10-06
ME02570B (me)	2017-06-20
CN102971308A (zh)	2013-03-13
LTC2552902I2 (lt)	2019-12-10
ES2536295T3 (es)	2015-05-22
HRP20150427T1 (hr)	2015-07-03
HK1175471A1 (en)	2013-07-05
HRP20161680T1 (hr)	2017-01-27
PT2552902E (pt)	2015-06-02
TWI458719B (zh)	2014-11-01
US20130296382A1 (en)	2013-11-07
LTPA2019507I1 (lt)	2019-04-25
LTC2924034I2 (lt)	2020-10-12
WO2011120133A1 (en)	2011-10-06
EP2552902A1 (en)	2013-02-06
HK1209121A1 (en)	2016-03-24
HUS1900022I1 (hu)	2019-05-28
CY2019025I2 (el)	2019-11-27
PL2552902T3 (pl)	2015-10-30
JP2013510800A (ja)	2013-03-28
IL233334A0 (en)	2014-09-01
KR20120128703A (ko)	2012-11-27
MX2012011379A (es)	2012-11-30
JP2013209405A (ja)	2013-10-10
BR112012024691A2 (pt)	2019-07-02
CY1118774T1 (el)	2017-07-12
LUC00113I2 (hu)	2024-05-22
MA34170B1 (fr)	2013-04-03
TW201139409A (en)	2011-11-16
PL2924034T3 (pl)	2017-07-31
SI2924034T1 (sl)	2017-05-31
CL2012002744A1 (es)	2012-12-14
NL300980I1 (nl)	2019-04-24
KR101421861B1 (ko)	2014-07-22
JP5886790B2 (ja)	2016-03-16
EA201290976A1 (ru)	2013-03-29
JP5281718B2 (ja)	2013-09-04
CN102971308B (zh)	2015-02-04
MY163979A (en)	2017-11-15
ECSP12012201A (es)	2012-10-30
SG184347A1 (en)	2012-11-29
US8486975B2 (en)	2013-07-16
IL222030A (en)	2014-07-31
CY2019025I1 (el)	2019-11-27
CO6630126A2 (es)	2013-03-01
SI2552902T1 (sl)	2015-10-30
ES2609636T3 (es)	2017-04-21
CA2794377C (en)	2015-06-16
HUE025336T2 (hu)	2016-03-29
GEP20156368B (en)	2015-09-25
ME02181B (me)	2015-10-20
NL300980I2 (nl)	2021-06-17
CY2019026I2 (el)	2020-05-29
NO2019019I1 (no)	2019-04-24
BR112012024691B1 (pt)	2020-11-17
RS54017B1 (sr)	2015-10-30
LUC00113I9 (hu)	2024-06-07
EP2552902B1 (en)	2015-03-11
AU2011235568B2 (en)	2013-09-12
PT2924034T (pt)	2017-01-06
LT2924034T (lt)	2016-12-27
LUC00114I2 (hu)	2020-07-10
TN2012000455A1 (en)	2014-01-30
AR080859A1 (es)	2012-05-16
LTPA2019506I1 (lt)	2019-04-25
LUC00114I1 (hu)	2019-04-17
DK2552902T3 (en)	2015-06-15
PH12012501923A1 (en)	2013-02-04
DK2924034T3 (en)	2017-02-06

Publication	Publication Date	Title
HUS1900021I1 (hu)	2019-05-28	Nem nukleozid reverz transzkriptáz inhibitorok
FR25C1006I1 (fr)	2025-04-04	Inhibiteurs de pyrazolyl-quinoxaline kinase
SMT201500271B (it)	2016-01-08	Inibitori di neprilisina
DK2448938T3 (da)	2014-08-25	Pyrimidinoner som pi3k-inhibitorer
SMT201700111B (it)	2017-03-08	Eterociclilammine come inibitori di pi3k
EP2604688A4 (en)	2014-03-12	VARIANTE REVERSE TRANSKRIPTASE
HRP20181786T1 (hr)	2019-02-08	Inhibitori aktivacije t-stanica
DK2371923T3 (da)	2013-05-06	Aflejringshæmmer
EP2768399A4 (en)	2015-04-08	Ligation clip
EP4141364C0 (en)	2025-09-10	FRIDGE
DK2421825T3 (da)	2014-02-03	Azetidinyldiamider som monoacylglycerollipase-inhibitorer
EP4300014C0 (en)	2025-07-16	FRIDGE
DE102010037468A8 (de)	2012-06-28	Chirurgischer Clip
FI20106299A0 (fi)	2010-12-08	Pistoolikotelo
EP2785183A4 (en)	2015-07-01	TRIAZOLPYRIDINON PDE10 INHIBITORS
BR112013025761A2 (pt)	2018-05-29	inibidores de hsp90
EP2690862A4 (en)	2015-10-21	DEPTH EXTENSION DEVICE
EP2563127A4 (en)	2013-11-06	PROLYLCARBOXYPEPTIDASE INHIBITORS
EP2549107A4 (en)	2014-05-07	Freezing machine
ES1074161Y (es)	2011-06-24	Lavabo
EP2663574A4 (en)	2014-12-17	RETRO VIRUS REPLICATION INHIBITORS
BR112013005966A2 (pt)	2016-05-03	refrigerador
FR2965072B3 (fr)	2012-10-26	Horloge
DK2527666T3 (da)	2015-01-05	Ekspansionsanker
TH1101003839B (th)	2016-05-19	ไพริมิดิโนนเป็นสารยับยั้ง pi3k